Richard Fajzel

Richard Fajzel has been appointed board chair of CQDM, a consortium of pharmaceutical firms that funds early-stage research for tools and technologies that accelerate drug discovery. Fajzel is VP business development at Exactis Innovation, a non-profit organization dedicated to improving cancer survivorship through innovation funded by the Networks of Centres of Excellence program. He spent 25 years at Pfizer in senior management roles including GM of the Canadian oncology unit and senior director US oncology accounts. Fajzel replaces Leon Gosselin who has retired….